To understand the impact of immunosuppressive TAMs in the TME of PCa, we evaluated CD163 staining in a cohort of 95 locally advanced PCa radical prostatectomy specimens selected for adverse pathology (pT2 with positive margins or ≥pT3, Table S2). Here, CD163 is linked to posterior cortical atrophy.